U. McCann

发表

Caffeine reversal of sleep deprivation effects on alertness and mood

Maria L. Thomas, G. Belenky, D. Penetar, 1993, Psychopharmacology.

Repetitive TMS combined with exposure therapy for PTSD: a preliminary study.

R. Post, E. Osuch, D. Luckenbaugh, 2009, Journal of anxiety disorders.

Drug abuse and dependence: hazards and consequences of heroin, cocaine and amphetamines

U. McCann, G. Ricaurte, U. Mccann, 2000 .

The effects of sleep deprivation on pain inhibition and spontaneous pain in women.

U. McCann, R. Edwards, J. Haythornthwaite, 2007, Sleep.

Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder

Peter Herscovitch, Brenda Benson, R. Post, 2001, Biological Psychiatry.

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Matthew W. Johnson, R. Griffiths, U. McCann, 2011, Psychopharmacology.

Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

D. Wong, U. McCann, R. Dannals, 1998, The Journal of Neuroscience.

Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders

I. Liberzon, L. Tecott, K. Overall, 2001, Psychopharmacology.

Identifying the serotonin transporter signal in Western blot studies of the neurotoxic potential of MDMA and related drugs

U. McCann, G. Ricaurte, Michael Mclane, 2011, Synapse.

Heating induces aggregation and decreases detection of serotonin transporter protein on western blots

U. McCann, G. Ricaurte, Michael Mclane, 2007, Synapse.

Assessing long-term effects of MDMA (Ecstasy)

U. McCann, G. Ricaurte, 2001, The Lancet.

Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates

U. McCann, G. Ricaurte, A. H. Mayne, 2005, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of 3,4‐methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4‐dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: Implications for mechanisms of neurotoxicity

U. McCann, G. Ricaurte, Melanie Mueller, 2011, Synapse.

Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate.

U. McCann, G. Ricaurte, Melanie Mueller, 2011, Chemical research in toxicology.

Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity

U. McCann, G. Ricaurte, F. Peters, 2009, Drug Metabolism and Disposition.

Further Studies on the Role of Metabolites in MDMA-induced Serotonergic Neurotoxicity

U. McCann, G. Ricaurte, F. Peters, 2009 .

Altered prolactin response to M‐chlorophenylpiperazine in monkeys previously treated with 3,4‐methylenedioxymethamphetamine (MDMA) or fenfluramine

U. McCann, G. Ricaurte, G. Hatzidimitriou, 2002, Synapse.

Adverse Reactions with 3,4-Methylenedioxymethamphetamine (MDMA; ‘Ecstasy’)

U. McCann, G. Ricaurte, S. O. Slate, 1996, Drug safety.

Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humans a

U. McCann, G. Ricaurte, U. Mccann, 1992, Annals of the New York Academy of Sciences.

Neuropathology of cocaine abuse

U. McCann, G. Ricaurte, U. Mccann, 1999 .

Anxiety and Cardiac Disease

B. Thombs, U. McCann, J. Fauerbach, 2005 .

Quantitative Positron Emission Tomography Studies of the Serotonin Transporter in Humans Previously Treated with the Appetite Suppressants Fenfluramine or Dexfenfluramine

Z. Szabo, U. McCann, R. Dannals, 2007, Molecular Imaging and Biology.

Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine

U. McCann, G. Ricaurte, Victoria Eligulashvili, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

NREM sleep cerebral blood flow before and after behavior therapy for chronic primary insomnia: preliminary single photon emission computed tomography (SPECT) data.

U. McCann, M. Perlis, Michael T. Smith, 2005, Sleep medicine.

Post-myocardial infarction depression.

B. Thombs, E. Bass, D. Ford, 2005, Evidence report/technology assessment.

Diffusion tensor imaging atlas-based analyses in major depression after mild traumatic brain injury.

Gwenn S. Smith, D. Yousem, D. Pham, 2012, The Journal of neuropsychiatry and clinical neurosciences.

Identification and Characterization of Metallothionein-1 and -2 Gene Expression in the Context of (±)3,4-Methylenedioxymethamphetamine-Induced Toxicity to Brain Dopaminergic Neurons

K. Becker, C. Cheadle, U. McCann, 2004, The Journal of Neuroscience.

Kindling versus Quenching

R. Post, M. Smith, U. McCann, 1997, Annals of the New York Academy of Sciences.

Racial differences in platelet serotonin polymorphisms in acute coronary syndrome.

L. Yanek, U. McCann, N. Faraday, 2021, Thrombosis research.

Chronic pain and depression. I. Classification of depression in chronic low back pain patients

K. Krishnan, J. Davidson, U. McCann, 1985, Pain.

Chronic pain and depression. II. Symptoms of anxiety in chronic low back pain patients and their relationship to subtypes of depression

J. Davidson, U. McCann, K. Krishnan, 1985, Pain.

What does the dexamethasone suppression test identify?

K. Krishnan, J. Davidson, U. McCann, 1985, Biological Psychiatry.

Dopamine is not essential for the development of methamphetamine-induced neurotoxicity

R. Palmiter, M. Darvas, U. McCann, 2010, Journal of neurochemistry.

Evidence against an essential role of endogenous brain dopamine in methamphetamine‐induced dopaminergic neurotoxicity

U. McCann, G. Ricaurte, Jie Yuan, 2001, Journal of neurochemistry.

Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity

U. McCann, G. Ricaurte, Jie Yuan, 2002, Journal of neurochemistry.

Acute dystonic reaction in normal humans caused by catecholamine depletion.

G. Belenky, D. Penetar, U. McCann, 1990, Clinical neuropharmacology.

Post‐Myocardial Infarction Depression: Summary

B. Thombs, E. Bass, D. Ford, 2005 .

Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.

U. McCann, G. Ricaurte, J. Katz, 1994, The Journal of pharmacology and experimental therapeutics.

Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.

U. McCann, G. Ricaurte, Una D. McCann, 1993, Journal of clinical psychopharmacology.

Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons

U. McCann, G. Ricaurte, R. Irvine, 2006, Neuropsychopharmacology.

Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences

U. McCann, G. Ricaurte, Melanie Mueller, 2011, Journal of Pharmacology and Experimental Therapeutics.

Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and Humans

U. McCann, M. Huestis, G. Ricaurte, 2009, Therapeutic drug monitoring.

Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) and Its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA That Develop After Typical Psychoactive Doses

U. McCann, G. Ricaurte, F. Peters, 2008, Journal of Pharmacology and Experimental Therapeutics.

Non-linear Pharmacokinetics of MDMA ( “ Ecstasy ” ) and its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA that Develop After Typical Psychoactive Doses

U. McCann, G. Ricaurte, F. Peters, 2008 .

Methylphenidate and brain dopamine neurotoxicity

U. McCann, G. Ricaurte, Jie Yuan, 1997, Brain Research.

A Comparison of the Effects of Intravenous Pentagastrin on Patients with Social Phobia, Panic Disorder and Healthy Controls

T. Uhde, U. McCann, M. Geraci, 1997, Neuropsychopharmacology.

Traumatic burn injury: Neuropsychiatric perspectives on risk, outcomes and treatment

U. McCann, J. Fauerbach, U. Mccann, 2009, International review of psychiatry.

Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal

R. Post, U. McCann, M. Geraci, 2002, Biological Psychiatry.

Ballatrophobia: when clowns aren't funny.

U. McCann, R. Austin, 1996, Anxiety.

Developments in the treatment of drug dependence

J. Bobes, U. McCann, U. Mccann, 2000 .

With Desipramine: A Double-Blind, Placebo-Controlled Study

W. Agras, U. McCann, 1990 .

Panic attacks in healthy volunteers treated with a catecholamine synthesis inhibitor

G. Belenky, D. Penetar, U. McCann, 1991, Biological Psychiatry.

Studies of (±)-3,4-Methylenedioxymethamphetamine (MDMA) Metabolism and Disposition in Rats and Mice: Relationship to Neuroprotection and Neurotoxicity Profile

U. McCann, G. Ricaurte, Melanie Mueller, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Plasma Drug Concentrations and Physiological Measures in ‘Dance Party’ Participants

Jason M. White, U. McCann, R. Irvine, 2006, Neuropsychopharmacology.

Major metabolites of(±)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons

U. McCann, G. Ricaurte, U. Mccann, 1991, Brain Research.

Effects of the 5-HT3 Antagonist, Ondansetron, on the Behavioral and Physiological Effects of Pentagastrin in Patients with Panic Disorder and Social Phobia

D. Murphy, R. Post, U. McCann, 1997, Neuropsychopharmacology.

Implications of Kindling And Quenching For the Possible Frequency Dependence Of rTMS

M. Frye, R. Post, M. George, 1997, CNS Spectrums.

Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, “ECSTASY”) and its potential to damage brain serotonin neurons

U. McCann, G. Ricaurte, U. Mccann, 2009, Neurotoxicity Research.

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies

U. McCann, G. Ricaurte, Victoria Eligulashvili, 2000, Neuropsychobiology.

Chapter 38 – Neuropsychiatric Complications of Substance Abuse

U. McCann, G. Ricaurte, J. Langston, 2008 .

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Z. Szabo, U. McCann, G. Ricaurte, 2000, Toxicology letters.

Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.

U. McCann, G. Ricaurte, U. Mccann, 1991, Journal of clinical psychopharmacology.

Repetitive transcranial magnetic stimulation for posttraumatic stress disorder.

E M Wassermann, R. Post, E. Wassermann, 1998, Archives of general psychiatry.

Repetitive TMS as a Probe in Anxiety Disorders: Theoretical Considerations and Case Reports

D. Murphy, J. Benjamin, B. Greenberg, 1997, CNS Spectrums.

Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study

U. McCann, G. Ricaurte, Victoria Eligulashvili, 1999, Psychopharmacology.

Sleep deprivation and impaired cognition possible role of brain catecholamines

Y. Shaham, G. Belenky, J. Gillin, 1992, Biological Psychiatry.

Neural plasticity and emotional memory

R. Post, E. Osuch, M. Smith, 1998, Development and Psychopathology.

Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep.

U. McCann, R. Allen, G. Ricaurte, 1993, Sleep.

Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

Y. Shaham, U. McCann, G. Ricaurte, 1994, Neuropsychopharmacology.

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

James Robert Brašić, D. Wong, U. McCann, 2008, Synapse.

Effect of Temperature on Dopamine Transporter Function and Intracellular Accumulation of Methamphetamine: Implications for Methamphetamine-Induced Dopaminergic Neurotoxicity

U. McCann, G. Ricaurte, Saejeong J. Kim, 2000, The Journal of Neuroscience.

Positron emission tomography of striatal serotonin transporters in Parkinson disease.

John Hilton, Dean F Wong, Zsolt Szabo, 2003, Archives of neurology.

Iodothyronine deiodination reaction types in several rat tissues: effects of age, thyroid status, and glucocorticoid treatment.

U. McCann, M. Kaplan, E. Shaw, 1984, Endocrinology.

Anatomical distribution of phenolic and tyrosyl ring iodothyronine deiodinases in the nervous system of normal and hypothyroid rats.

P. Larsen, U. McCann, J. L. Leonard, 1981, Endocrinology.

Recognition and management of complications of new recreational drug use

U. McCann, G. Ricaurte, Una D McCann, 2005, The Lancet.

Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal.

U. McCann, A. Budney, Erin Curran, 2011, Drug and alcohol dependence.

Symptoms of depression predict change in physical health after burn injury.

B. Thombs, U. McCann, J. Lawrence, 2007, Burns : journal of the International Society for Burn Injuries.

Nonpurging bulimia: A distinct subtype of bulimia nervosa

W. Agras, U. McCann, R. King, 1991 .

Individual variation in rapid eye movement sleep is associated with pain perception in healthy women: preliminary data.

U. McCann, R. Edwards, Gregory L. Stonerock, 2005, Sleep.

Effect of Glucoprivation on Serotonin Neurotoxicity Induced by Substituted Amphetamines

U. McCann, G. Ricaurte, Jie Yuan, 2002, Journal of Pharmacology and Experimental Therapeutics.

Fenfluramine's appetite suppression and serotonin neurotoxicity are separable.

U. McCann, G. Ricaurte, J. Yuan, 1995, European journal of pharmacology.

Effects of MDMA on the Human Nervous System

U. McCann, G. Ricaurte, U. Mccann, 2014 .

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

U. McCann, G. Ricaurte, Jie Yuan, 2000, Neuropsychobiology.

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.

U. McCann, G. Ricaurte, T. Steele, 1994, Addiction.

Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

U. McCann, G. Ricaurte, G. Hatzidimitriou, 2002, Science.

Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers

U. McCann, G. Ricaurte, A. Schwartz, 2009, Neurology.

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance

Z. Szabo, U. McCann, R. Dannals, 2008, Psychopharmacology.

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms

U. McCann, G. Ricaurte, U. Mccann, 2007, TheScientificWorldJournal.

MDMA (“Ecstasy”) and panic disorder: Induction by a single dose

U. McCann, G. Ricaurte, U. Mccann, 1992, Biological Psychiatry.

Caveat Emptor: Editors Beware

U. McCann, G. Ricaurte, U. Mccann, 2001, Neuropsychopharmacology.

Memory impairment in abstinent MDMA ("Ecstasy") users

U. McCann, G. Ricaurte, K. Bolla, 1998, Neurology.

Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain

J. Bobes, P. Sáiz, M. Bascarán, 2002, European Addiction Research.

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users

D. Murphy, U. McCann, G. Ricaurte, 1999, Psychopharmacology.

"Ecstasy" and serotonin neurotoxicity: new findings raise more questions.

M. Molliver, U. McCann, G. Ricaurte, 2001, Archives of general psychiatry.

Amphetamine neurotoxicity: accomplishments and remaining challenges

U. McCann, G. Ricaurte, Una D McCann, 2004, Neuroscience & Biobehavioral Reviews.

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.

L. Seiden, U. McCann, G. Ricaurte, 1997, JAMA.

Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use.

R. Griffiths, U. McCann, M. Mintzer, 2012, Experimental and clinical psychopharmacology.

Changes in Gene Expression Linked to Methamphetamine-Induced Dopaminergic Neurotoxicity

K. Becker, T. Barrett, U. McCann, 2002, The Journal of Neuroscience.

Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression

U. McCann, N. Gould, D. Vaidya, 2019, Psychosomatic medicine.

Motor dynamics encoding in the rostral zone of the cat cerebellar flocculus during vertical optokinetic eye movements

U. McCann, G. Ricaurte, U. Mccann, 2000 .

REVIEW ■ : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System

U. McCann, G. Ricaurte, K. A. Lowe, 1997 .

Neuroimaging of MDMA-Induced Neurotoxicity

Z. Szabo, U. McCann, G. Ricaurte, 2002 .

Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration

U. McCann, G. Ricaurte, J. M. Moerschbaecher, 2002, Psychopharmacology.

Correlates of apathy during the first year after traumatic brain injury.

J. Brandt, D. Schretlen, U. McCann, 2013, Psychosomatics.

Performance characteristics of depression screening instruments in survivors of acute myocardial infarction: review of the evidence.

B. Thombs, E. Bass, U. McCann, 2007, Psychosomatics.

Depression following acute myocardial infarction: a prospective relationship with ongoing health and function.

B. Thombs, U. McCann, J. Fogel, 2005, Psychosomatics.

Does acute TBI-related sleep disturbance predict subsequent neuropsychiatric disturbances?

U. McCann, Dingfen Han, V. Rao, 2014, Brain injury.

Sleep Deprivation Differentially Impairs Cognitive Performance in Abstinent Methylenedioxymethamphetamine (“Ecstasy”) Users

U. McCann, G. Ricaurte, F. Sgambati, 2009, The Journal of Neuroscience.

Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB

Zsolt Szabo, Z. Szabo, U. McCann, 2005, Neuropsychopharmacology.

Relationship between Temperature, Dopaminergic Neurotoxicity, and Plasma Drug Concentrations in Methamphetamine-Treated Squirrel Monkeys

U. McCann, G. Ricaurte, Melanie Mueller, 2006, Journal of Pharmacology and Experimental Therapeutics.

Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study.

W. Agras, U. McCann, W S Agras, 1990, The American journal of psychiatry.

The Effects of L-Dihydroxyphenylalanine on Alertness and Mood in α-Methyl-Para-Tyrosine-Treated Healthy Humans

G. Belenky, U. McCann, D. Thorne, 1995, Neuropsychopharmacology.

Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

Jie Yuan, U. McCann, G. Ricaurte, 2006, Neuropsychopharmacology.

Sleep disturbance after mild traumatic brain injury: indicator of injury?

U. McCann, D. Efron, V. Rao, 2011, The Journal of neuropsychiatry and clinical neurosciences.

Low-Frequency Right Repetitive Transcranial Magnetic Stimulation for the Treatment of Depression After Traumatic Brain Injury: A Randomized Sham-Controlled Pilot Study.

D. Yousem, S. Mori, S. Vaishnavi, 2019, The Journal of neuropsychiatry and clinical neurosciences.

Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users

U. McCann, R. Edwards, G. Ricaurte, 2011, Psychopharmacology.

The Effect of Catecholamine Depletion by Alpha-Methyl-Para-Tyrosine on Measures of Cognitive Performance and Sleep in Abstinent MDMA Users

U. McCann, G. Ricaurte, S. Peterson, 2007, Neuropsychopharmacology.

Characteristics of Depressive Symptoms in Cardiovascular Disease

U. McCann, Nae-Yuh Wang, Marlene S Williams, 2019 .

Effects of Catecholamine Depletion on Alertness and Mood in Rested and Sleep Deprived Normal Volunteers

Maria L. Thomas, Y. Shaham, G. Belenky, 1993, Neuropsychopharmacology.

Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug.

U. McCann, G. Ricaurte, G. Hatzidimitriou, 1997, The Journal of pharmacology and experimental therapeutics.

A Murine Dopamine Neuron-Specific cDNA Library and Microarray: Increased COXI Expression during Methamphetamine Neurotoxicity

M. Ko, W. Wood, K. Becker, 2001, Neurobiology of Disease.

Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

U. McCann, G. Ricaurte, G. Hatzidimitriou, 2008, Neuropsychopharmacology.

Comparison of (+)-11C-McN5652 and 11C-DASB as Serotonin Transporter Radioligands Under Various Experimental Conditions

John Hilton, Alan A. Wilson, Zsolt Szabo, 2002 .

Comparison of the daytime sleep and performance effects of zolpidem versus triazolam

T. Balkin, G. Belenky, U. McCann, 2005, Psychopharmacology.

Pathological Laughter and Crying and Psychiatric Comorbidity After Traumatic Brain Injury.

U. McCann, Durga Roy, Dingfen Han, 2015, The Journal of neuropsychiatry and clinical neurosciences.